Phaedra S. Chrousos's most recent trade in Vanda Pharmaceuticals Inc was a trade of 59,225 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Phaedra S. Chrousos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 59,225 | 123,350 (0%) | 0% | 0 | Common Stock |